Call: Personalised Medicine
Call identifier: H2020-SC1-2016-2017
Publication date: 14-10-2015

Beneficiaries will be allowed to charge the cost of clinical trials on the basis of unit costs established in line with a methodology set up in the Commission Decision (C2014) 1393, which is available on the Participant Portal.

Topics (deadline is 16-2-2016):

  • SC1-PM-18-2016:Big Data supporting Public Health policies
  • SC1-PM-13-2016:PPI for deployment and scaling up of ICT solutions for active and healthy ageing
  • SC1-PM-12-2016:PCP – eHealth innovation in empowering the patient
  • SC1-HCO-16-2016:Standardisation needs in the field of ICT for Active and Healthy Ageing
  • SC1-HCO-15-2016:EU eHealth Interoperability conformity assessment
  • SC1-HCO-14-2016:EU-US interoperability roadmap
  • SC1-HCO-13-2016:Healthcare Workforce IT skills
  • SC1-HCO-12-2016:Digital health literacy
  • SC1-HCO-11-2016:Coordinated action to support the recognition of Silver Economy opportunities arising from demographic change
  • SC1-HCO-10-2016:Support for Europe’s leading Health ICT SMEs

Topics (deadline is 13-4-2016):

  • SC1-HCO-01-2016:Valorisation of FP7 Health and H2020 SC1 research results
  • SC1-HCO-02-2016:Standardisation of pre-analytical and analytical procedures for in vitro diagnostics in personalised medicine
  • SC1-HCO-04-2016:Towards globalisation of the Joint Programming Initiative on Antimicrobial resistance
  • SC1-HCO-05-2016:Coordinating personalised medicine research
  • SC1-HCO-06-2016:Towards an ERA-NET for building sustainable and resilient health system models
  • SC1-PM-04-2016:Networking and optimising the use of population and patient cohorts at EU level
  • SC1-PM-05-2016:The European Human Biomonitoring Initiative
  • SC1-PM-06-2016:Vaccine development for malaria and/or neglected infectious diseases
  • SC1-PM-09-2016:New therapies for chronic diseases
  • SC1-PM-11-2016-2017:Clinical research on regenerative medicine
  • SC1-PM-21-2016:Implementation research for scaling-up of evidence based innovations and good practice in Europe and low- and middle-income countries

For further information, please visit European Commission website.